Addiction to the nicotine gum in never smokers

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Etter, Jean François ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM; NICOTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTERNET; MALE; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; TOBACCO DEPENDENCE; ADDICTION; CHEMICALLY INDUCED DISORDER; CHEWING GUM; DOUBLE BLIND PROCEDURE; HEALTH SURVEY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ADULT; BEHAVIOR, ADDICTIVE; CHEWING GUM; DOUBLE-BLIND METHOD; FEMALE; HEALTH SURVEYS; HUMANS; INTERNET; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINE;

EID: 34547691152     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-159     Document Type: Article

References (35)

1. Nicotine replacement therapy for smoking cessation: Cochrane systematic review. L Stead T Lancaster, Int J Epidemiol 2005 34 1001 2 10.1093/ije/dyi171
2. When California smokers use nicotine replacement therapy, most are trying to quit smoking. WK Al-Delaimy EA Gilpin JP Pierce, Tob Control 2005 14 359 60 10.1136/tc.2005.012989 16183988
3. Public health benefit of over-the-counter nicotine medications. S Shiffman J Gitchell JM Pinney SL Burton KE Kemper EA Lara, Tob Control 1997 6 306 10 9583628
4. Dependence potential and abuse liability of nicotine replacement therapies. JR Hughes, Biomed Pharmacother 1989 43 11 7 10.1016/0753-3322(89) 90185-6 2659095
5. Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample. JR Hughes JL Pillitteri PW Callas R Callahan M Kenny, Nicotine Tob Res 2004 6 79 84 10.1080/14622200310001656894 14982691
6. Dependence on and abuse of nicotine replacement medications: an update. JR Hughes, Nicotine safety and toxicity Oxford: Oxford University Press, Benowitz NL, 1998
7. Smoking cessation treatment on the Internet: content, quality, and usability. B Bock A Graham C Sciamanna J Krishnamoorthy J Whiteley R Carmona-Barros R Niaura D Abrams, Nicotine Tob Res 2004 6 207 19 10.1080/14622200410001676332 15203794
8. Effectiveness of a computer-tailored smoking cessation program: a randomized trial. JF Etter TV Perneger, Arch Intern Med 2001 161 2596 601 10.1001/archinte.161.21.2596 11718591
9. Survey for users of nicotine chewing gums. http://www.stop-tabac.ch/en/ Gums/
10. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. TF Heatherton LT Kozlowski RC Frecker KO Fagerstrom, Br J Addict 1991 86 1119 27 10.1111/j.1360-0443.1991.tb01879.x 1932883
11. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. S Shiffman A Waters M Hickcox, Nicotine Tob Res 2004 6 327 48 10.1080/1462220042000202481 15203807
12. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. JF Etter J Le Houezec TV Perneger, Neuropsychopharmacology 2003 28 359 70 10.1038/sj.npp.1300030 12589389
13. A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerstrom test for nicotine dependence. JF Etter, Drug Alcohol Depend 2005 77 259 68 10.1016/j.drugalcdep.2004.08.015 15734226
14. The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? ET Moolchan A Radzius DH Epstein G Uhl DA Gorelick JL Cadet JE Henningfield, Addict Behav 2002 27 101 13 10.1016/S0306-4603(00)00171-4 11800217
15. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. LT Kozlowski CQ Porter CT Orleans MA Pope T Heatherton, Drug Alcohol Depend 1994 34 211 6 10.1016/0376-8716(94)90158-9 8033758
16. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition, (DSM-IV) Washington D.C., American Psychiatric Association 1994
17. World Health Organization, The ICD-10: classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines Geneva, World Health Organization 1992
18. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. DG Davila RD Hurt KP Offord CD Harris JW Shepard Jr, Am J Respir Crit Care Med 1994 150 469 74 8049831
19. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. WJ Sandborn WJ Tremaine JA Leighton GM Lawson BJ Zins RF Compton DC Mays JJ Lipsky KP Batts KP Offord RD Hurt J Green, Aliment Pharmacol Ther 1997 11 663 71 10.1046/j.1365-2036.1997.00208.x 9305473
20. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. WJ Sandborn WJ Tremaine KP Offord GM Lawson BT Petersen KP Batts IT Croghan LC Dale DR Schroeder RD Hurt, Ann Intern Med 1997 126 364 71 9054280
21. Recurrent aphthous ulcers and nicotine. R Bittoun, Med J Aust 1991 154 471 2 2005845
22. Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers. D Kalman SS Smith, Nicotine Tob Res 2005 7 317 33 10.1080/14622200500125385 16085500
23. Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. KA Perkins D Gerlach M Broge JE Grobe A Wilson, Exp Clin Psychopharmacol 2000 8 462 71 10.1037/1064-1297.8.4.462 11127418
24. Dissociation of nicotine tolerance from tobacco dependence in humans. KA Perkins D Gerlach M Broge JE Grobe M Sanders C Fonte J Vender C Cherry A Wilson, J Pharmacol Exp Ther 2001 296 849 56 11181916
25. Use of nicotine replacement therapy in adolescent smokers and nonsmokers. LM Klesges KC Johnson G Somes S Zbikowski L Robinson, Arch Pediatr Adolesc Med 2003 157 517 22 10.1001/archpedi.157.6.517 12796230
26. Post marketing surveillance of nicotine replacement products. EH Adams B Korberly MK Maquire MA Franzon, Poster presented at the conference of the Society for Research on Nicotine and Tobacco, Paris, France, 19-22 September 2001
27. Drug counselor report of adolescents abuse of nicotine replacement therapy. A Hyland D Bradford J Gitchell, J Addict Dis 2005 24 105 13 10.1300/J069v24n04_08 16368660
28. Use of of nicotine replacement therapy with and without prescription. Future directions in nicotine replacement therapy (proceedings). Paris, October 1993. LM Ramström, Chester: ADIS International 1994
29. Post-marketing reports of adverse events and prolonged use of nicotine polacrilex resin and the nicotine patch. DA Spyker RJ Alderfer RA Goetsch AW Longmire ED Kramer, Rockville: Food and Drug Administration, unpublished manuscript 29 March 1996
30. Post-marketing adverse events associated with the nicotine patch and polacrilex resin in the United States. [Abstract]. DA Spyker RJ Alderfer RA Goetsch GD Armstrong AW Longmire ED Kramer, Clin Pharmacol Ther 1996 59 159
31. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. AM Joseph SM Norman LH Ferry, N Engl J Med 1996 335 1792 8 10.1056/NEJM199612123352402 8943160
32. A strategy of smoking cessation combined with nicotine patch therapy reduces the extent of exercise-induced myocardial ischaemia. JJ Mahmarian LA Moye GA Nasser, J Am Coll Cardiol 1997 30 125 30 10.1016/S0735-1097(97)00128-9 9207632
33. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. RP Murray WC Bailey K Daniels WM Bjornson K Kurnow JE Connett MA Nides JP Kiley, Chest 1996 109 438 45 8620719
34. Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample. S Shiffman JR Hughes JL Pillitteri SL Burton, Tob Control 2003 12 310 6 10.1136/tc.12.3.310 12958394
35. Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking. S Shiffman JR Hughes ME Di Marino CT Sweeney, Addiction 2003 98 1747 53 10.1111/j.1360-0443.2003.00575.x 14651507